Date
- Wednesday, 15 December 2010, All day
Location
- European Medicines Agency, Amsterdam, the Netherlands
The conference highlighted a range of scientific topics including the role the Agency can play to best support regulatory sciences. Topics included models to support benefit-risk assessment, the challenges associated with regulation of biotechnological medicinal products, addressing the efficacy-effectiveness gap of medicines, the appropriate use of health data to support medicines regulation, ongoing efforts to detect safety issues, and novel statistical methodologies for clinical trials.